Heterologous recombinant expression of non-originator NISTmAb

The successful development and regulatory approval of originator and biosimilar therapeutic proteins requires a systems approach to upstream and downstream processing as well as product characterization and quality control. Innovation in process design and control, product characterization strategie...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:MAbs
Main Authors: Kashi, Lila, Yandrofski, Katharina, Preston, Renae J., Arbogast, Luke W., Giddens, John P., Marino, John P., Schiel, John E., Kelman, Zvi
Formato: Artigo
Idioma:Inglês
Publicado: Taylor & Francis 2018
Assuntos:
Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6152460/
https://ncbi.nlm.nih.gov/pubmed/29958062
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2018.1486355
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares